Skip to main content

Visualization and Analysis of Parkinson’s Disease Status and Therapy Patterns

  • Conference paper
  • First Online:
Discovery Science (DS 2018)

Part of the book series: Lecture Notes in Computer Science ((LNAI,volume 11198))

Included in the following conference series:

  • 814 Accesses

Abstract

Parkinson’s disease is a neurodegenerative disease affecting people worldwide. Since the reasons for Parkinson’s disease are still unknown and currently there is no cure for the disease, the management of the disease is directed towards handling of the underlying symptoms with antiparkinson medications. In this paper, we present a method for visualization of the patients’ overall status and their antiparkinson medications therapy. The purpose of the proposed visualization method is multi-fold: understanding the clinicians’ decisions for therapy modifications, identification of the underlying guidelines for management of Parkinson’s disease, as well as identifying treatment differences between groups of patients. The resulting patterns of disease progression show that there are differences between male and female patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    The visualization method is closely related to the PPMI data and the cluster label results from [22]. As the permission to use the PPMI data can be obtained only from www.ppmi-info.org/data, we cannot share the complete solution but the code is available upon request to the first author of the paper.

  2. 2.

    A skip gram, e.g., a d-skip-n-gram, is a sequence of n items (disease progression phases, in our case), which are not necessarily consecutive, but gaps of up to d intermediate items are tolerated. The advantage of skip-grams over ordinary n-grams is that they are more noise tolerant and offer stronger statistical support for possibly interrupted sequence patterns.

References

  1. Blockeel, H., Raedt, L.D., Ramon, J.: Top-down induction of clustering trees. In: Proceedings of the 15th International Conference on Machine Learning, ICML 1998. pp. 55–63 (1998)

    Google Scholar 

  2. Dalrymple-Alford, J., et al.: The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 75(19), 1717–1725 (2010)

    Article  Google Scholar 

  3. Ferreira, J., et al.: Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson’s disease. Eur. J. Neurol. 20(1), 5–15 (2013)

    Article  Google Scholar 

  4. Fox, S.H., et al.: The movement disorder society evidence-based medicine review update: treatments for the motor symptoms of Parkinson’s disease. Mov. Disord. 26(S3), S2–S41 (2011)

    Article  Google Scholar 

  5. Goetz, C., Luo, S., Wang, L., Tilley, B., LaPelle, N., Stebbins, G.: Handling missing values in the MDS-UPDRS. Mov. Disord. 30(12), 1632–1638 (2015)

    Article  Google Scholar 

  6. Goetz, C., et al.: Movement disorder society-sponsored revision of the unified Parkinson’s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23(15), 2129–2170 (2008)

    Google Scholar 

  7. Guthrie, D., Allison, B., Liu, W., Guthrie, L., Wilks, Y.: A closer look at skip-gram modelling. In: Proceedings of the 5th International Conference on Language Resources and Evaluation, LREC 2006. pp. 1–4 (2006)

    Google Scholar 

  8. Kosara, R., Miksch, S.: Visualization methods for data analysis and planning in medical applications. Int. J. Med. Inform. 68(1), 141–153 (2002)

    Article  Google Scholar 

  9. Marek, K., et al.: The Parkinson’s progression markers initiative (PPMI). Prog. Neurobiol. 95(4), 629–635 (2011)

    Google Scholar 

  10. National Collaborating Centre for Chronic Conditions: Parkinson’s Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. Royal College of Physicians, London (2006)

    Google Scholar 

  11. Olanow, W., Watts, R., Koller, W.: An algorithm (decision tree) for the management of Parkinson’s disease (2001): treatment guidelines. Neurology 56(suppl 5), S1–S88 (2001)

    Article  Google Scholar 

  12. Plaisant, C., Milash, B., Rose, A., Widoff, S., Shneiderman, B.: Lifelines: visualizing personal histories. In: Proceedings of the SIGCHI Conference on Human Factors in Computing Systems, pp. 221–227. CHI 1996, ACM, New York, NY, USA (1996)

    Google Scholar 

  13. Seppi, K., et al.: The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson’s disease. Mov. Disord. 26(S3) (2011)

    Article  Google Scholar 

  14. Struyf, J., Ženko, B., Blockeel, H., Vens, C., Džeroski, S.: CLUS: User’s Manual (2010)

    Google Scholar 

  15. Tsanas, A.: Accurate telemonitoring of Parkinsons disease symptom severity using nonlinear speech signal processing and statistical machine learning. Ph.D. thesis, Oxford University, UK (2012)

    Google Scholar 

  16. Tsanas, A., Little, M., McSharry, P., Ramig, L.: Accurate telemonitoring of Parkinson’s disease progression by noninvasive speech tests. IEEE Trans. Biomed. Eng. 57(4), 884–893 (2010)

    Article  Google Scholar 

  17. Tsanas, A., Little, M.A., McSharry, P.E., Ramig, L.O.: Accurate telemonitoring of Parkinson’s disease progression by noninvasive speech tests. IEEE Trans. Biomed. Eng. 57(4), 884–893 (2010)

    Article  Google Scholar 

  18. Tsanas, A., Little, M.A., McSharry, P.E., Ramig, L.O.: Enhanced classical Dysphonia measures and sparse regression for telemonitoring of Parkinson’s disease progression. In: Proceedings of the IEEE International Conference on Acoustics Speech and Signal Processing, ICASSP 2010, pp. 594–597. IEEE (2010)

    Google Scholar 

  19. Tsanas, A., Little, M.A., McSharry, P.E., Spielman, J., Ramig, L.O.: Novel speech signal processing algorithms for high-accuracy classification of Parkinson’s disease. IEEE Trans. Biomed. Eng. 59(5), 1264–1271 (2012)

    Article  Google Scholar 

  20. Tufte, E.R.: The Visual Display of Quantitative Information. Graphics Press, Cheshire, CT, USA (2001)

    Google Scholar 

  21. Valmarska, A., Miljkovic, D., Konitsiotis, S., Gatsios, D., Lavrač, N., Robnik-Šikonja, M.: Symptoms and medications change patterns for Parkinson’s disease patients stratification. Artif. Intell. Med. (2018). https://doi.org/10.1016/j.artmed.2018.04.010

  22. Valmarska, A., Miljkovic, D., Lavrač, N., Robnik-Šikonja, M.: Analysis of medications change in Parkinson’s disease progression data. J. Intell. Inf. Syst. 51(2), 301–337 (2018)

    Article  Google Scholar 

  23. Valmarska, A., Miljkovic, D., Robnik-Šikonja, M., Lavrač, N.: Multi-view approach to Parkinson’s disease quality of life data analysis. In: Proceedings of the International Workshop on New Frontiers in Mining Complex Patterns, pp. 163–178. Springer (2016)

    Google Scholar 

  24. Visser, M., Marinus, J., Stiggelbout, A.M., Van Hilten, J.J.: Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov. Disord. 19(11), 1306–1312 (2004)

    Article  Google Scholar 

  25. Washburn, R.A., Smith, K.W., Jette, A.M., Janney, C.A.: The physical activity scale for the elderly (PASE): development and evaluation. J. Clin. Epidemiol. 46(2), 153–162 (1993)

    Article  Google Scholar 

Download references

Acknowledgments

This work was supported by the PD_manager project, funded within the EU Framework Programme for Research and Innovation Horizon 2020 grant 643706. We acknowledge also the support of the Slovenian Research Agency (research core funding program P2-0103 and project P2-0209).

Data used in the preparation of this article were obtained from the Parkinsons Progression Markers Initiative (PPMI) (www.ppmi-info.org/data). For up-to-date information on the study, visit www.ppmi-info.org. PPMI—a public-private partnership—is funded by the Michael J. Fox Foundation for Parkinson’s Research and funding partners. Corporate Funding Partners: AbbVie, Avid Radiopharmaceuticals, Biogen, BioLegend, Bristol-Myers Squibb, GE Healthcare, GLAXOSMITHKLINE (GSK), Eli Lilly and Company, Lundbeck, Merck, Meso Scale Discovery (MSD), Pfizer Inc, Piramal Imaging, Roche, Sanofi Genzyme, Servier, Takeda, Teva, UCB. Philanthropic Funding Partners: Golub Capital. List of funding partners can be also found at www.ppmi-info.org/fundingpartners.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anita Valmarska .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Valmarska, A., Miljkovic, D., Robnik–Šikonja, M., Lavrač, N. (2018). Visualization and Analysis of Parkinson’s Disease Status and Therapy Patterns. In: Soldatova, L., Vanschoren, J., Papadopoulos, G., Ceci, M. (eds) Discovery Science. DS 2018. Lecture Notes in Computer Science(), vol 11198. Springer, Cham. https://doi.org/10.1007/978-3-030-01771-2_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-01771-2_30

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-01770-5

  • Online ISBN: 978-3-030-01771-2

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics